RAPT Therapeutics, Inc.
Pharmaceutical Preparations · SOUTH SAN FRANCISCO · CA
High confidence (85%)
Updated Oct 11, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.
Latest material event: RAPT Therapeutics, Inc. received a delisting notice from its exchange (Mar 3, 2026)
Timeline
Every material event, newest first. History is never overwritten.
RAPT Therapeutics, Inc. received a delisting notice from its exchange
Mar 3, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information contained in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. In connection with the closing of the Merger, the Company (i) notified The Nasdaq Stock Market LLC ( Nasdaq ) that the Merger was consummated and (ii) requested that Nasdaq (A) halt trading of and delist the Shares effective before the opening of trading on March 3, 2026, and (B) file with the SEC a Form 25 Notification of Removal from L…”
RAPT Therapeutics, Inc. was delisted from its exchange
Mar 3, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001673772 RAPT Therapeutics, Inc. 001-38997 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 (650) 489-9000 Common Stock 17 CFR 240.12d2-2(a)(3) Jennifer Fainer CDO Analyst 2026-03-03”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- SEC CIK
- 0001673772
- Website
- —
- —
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Also known as
- FLX Bio, Inc., RAPT Therapeutics, Inc.
- Legal entities
- RAPT Therapeutics, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
RAPT Therapeutics, Inc. — Pharmaceutical Preparations (SIC 2834) — SOUTH SAN FRANCISCO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001673772 RAPT Therapeutics, Inc. 001-38997 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 (650) 489-9000 Common Stock 17 CFR 240.12d2-2(a)(3) Jennifer Fainer CDO Analyst 2026-03-03
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information contained in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. In connection with the closing of the Merger, the Company (i) notified The Nasdaq Stock Market LLC ( Nasdaq ) that the Merger was consummated and (ii) requested that Nasdaq (A) halt trading of and delist the Shares effective before the opening of trading on March 3, 2026, and (B) file with the SEC a Form 25 Notification of Removal from L…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:32 AM
The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.